Bioteque Corporation (TPEX: 4107)

Market Cap	8.90B
Revenue (ttm)	2.03B
Net Income (ttm)	501.47M
Shares Out	69.30M
EPS (ttm)	7.20
PE Ratio	17.85
Forward PE	23.32
Dividend	4.50 (3.46%)
Ex-Dividend Date	Jul 30, 2024

Volume	141,455
Open	129.00
Previous Close	130.00
Day's Range	128.00 - 130.00
52-Week Range	102.00 - 147.50
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It also offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and ur...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2023, Bioteque's revenue was 1.94 billion, a decrease of -3.26% compared to the previous year's 2.01 billion. Earnings were 452.55 million, a decrease of -8.31%.